Baxter
BAX
#870
Rank
$21.80 B
Marketcap
$42.80
Share price
0.27%
Change (1 day)
6.83%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

EPS for Baxter (BAX)

EPS in 2023 (TTM): $5.12

According to Baxter's latest financial reports the company's current EPS (TTM) is $5.12. In 2022 the company made an earnings per share (EPS) of -$4.83 a decrease over its 2021 EPS that were of $2.56.

EPS history for Baxter from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.12-206%
2022-$4.83-288.67%
2021$2.5618.52%
2020$2.1610.2%
2019$1.96-34.45%
2018$2.99126.52%
2017$1.32-85.45%
2016$9.07411.9%
2015$1.77-61.48%
2014$4.6024.32%
2013$3.70-12.32%
2012$4.227.93%
2011$3.9161.57%
2010$2.42-33.52%
2009$3.6412.69%
2008$3.2321.89%
2007$2.6523.26%
2006$2.1538.71%
2005$1.55146.03%
2004$0.63-58%
2003$1.5017.8%
2002$1.2712.19%
2001$1.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.72-46.88%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$15.34 199.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.55 8.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.82-83.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.81 33.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.01-80.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.02-139.45%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.74-66.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.29-125.20%๐Ÿ‡บ๐Ÿ‡ธ USA